Cargando…

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

BACKGROUND: Adjuvant chemotherapy for resected early stage NSCLC provides modest survival benefit. Bevacizumab, a monoclonal antibody directed against vascular endothelial growth factor, improves outcomes when added to platinum-based chemotherapy in advanced stage non-squamous NSCLC. We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakelee, Heather A., Dahlberg, Suzanne E., Keller, Steven M., Tester, William J., Gandara, David R., Graziano, Stephen L., Adjei, Alex, Leighl, Natasha B., Aisner, Seena C., Rothman, Jan M., Patel, Jyoti D., Sborov, Mark D., McDermott, Sean R., Perez-Soler, Roman, Traynor, Anne M., Butts, Charles, Evans, Tracey, Shafqat, Atif, Chapman, Andrew E., Kasbari, Samer S., Horn, Leora, Ramalingam, Suresh S., Schiller, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789803/ https://www.ncbi.nlm.nih.gov/pubmed/29129443 http://dx.doi.org/10.1016/S1470-2045(17)30691-5

Ejemplares similares

Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC
por: Varlotto, John M., et al.
Publicado: (2022)

Epistolario de Nueva España, 1505-1818
por: Paso y Troncoso, Francisco del, 1842-1916
Publicado: (1939)

The Royal College of Surgeons of Edinburgh. Historical Notes from 1505 to 1905
por: Packard, Francis R.
Publicado: (1926)

1505. Antiviral and Antibiotic Prescribing Among Patients at an Ambulatory Cancer Center with Laboratory-Confirmed Influenza
por: Sorey, Woody, et al.
Publicado: (2020)

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a phase 2 randomised controlled trial
por: Neal, Joel W., et al.
Publicado: (2016)

1505. Shorter-Course Antibiotic Treatment for Pediatric Ventilator-Associated Tracheitis Is Safe and Effective
por: Grabic, Mirela, et al.
Publicado: (2019)

Phosphorylation of S1505 in the cardiac Na+ channel inactivation gate is required for modulation by protein kinase C
Publicado: (1996)

Achilles Pirmin Gasser (1505–1577) Arzt und Naturforscher Historiker und Humanist, Briefwechsel
Publicado: (1976)

Effect of culture parameters on the heat tolerance and inorganic polyphosphate accumulation by Lacticaseibacillus rhamnosus CRL1505, a multifunctional bacterium
por: Correa Deza, M. A., et al.
Publicado: (2023)

Draft Genome Sequence of Lactobacillus rhamnosus CRL1505, an Immunobiotic Strain Used in Social Food Programs in Argentina
por: Taranto, María Pía, et al.
Publicado: (2013)

Book Review: ‘A famous and flourishing society’: the history of the Royal College of Surgeons of Edinburgh 1505–2005
por: Sturdy, Steve
Publicado: (2007)

Potentially large post-1505 AD earthquakes in western Nepal revealed by a lake sediment record
por: Ghazoui, Z., et al.
Publicado: (2019)

Inorganic polyphosphate from the immunobiotic Lactobacillus rhamnosus CRL1505 prevents inflammatory response in the respiratory tract
por: Correa Deza, María A., et al.
Publicado: (2021)

Inorganic salts and intracellular polyphosphate inclusions play a role in the thermotolerance of the immunobiotic Lactobacillus rhamnosus CRL 1505
por: Correa Deza, María A., et al.
Publicado: (2017)

PO-1505 Phone call triage for patients admission in a radiotherapy department during COVID 19 pandemic
por: Santo, B., et al.
Publicado: (2021)

1505. Clinical characterization of TB/HIV naive coinfection patients enrolled in a TB program in Cali - Colombia.
por: Muñoz-Lombo, Jenny Patricia, et al.
Publicado: (2023)

Are the immunomodulatory properties of Lactobacillus rhamnosus CRL1505 peptidoglycan common for all Lactobacilli during respiratory infection in malnourished mice?
por: Kolling, Yanina, et al.
Publicado: (2018)

Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
por: Garcia-Castillo, Valeria, et al.
Publicado: (2020)

Safety and efficacy of Avizyme(®) 1505 (endo‐1,4‐beta‐xylanase, subtilisin and alpha‐amylase) for all poultry species
por: Bampidis, Vasileios, et al.
Publicado: (2020)

Leiomyoma of deep soft tissue mimicking calcific myonecrosis
por: Fitzhugh, Valerie A., et al.
Publicado: (2016)

Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505
por: Kitazawa, Haruki, et al.
Publicado: (2014)

Concerns and Support after One Year of COVID-19 in Austria: A Qualitative Study Using Content Analysis with 1505 Participants
por: Schaffler, Yvonne, et al.
Publicado: (2021)

The Mucus Binding Factor Is Not Necessary for Lacticaseibacillus rhamnosus CRL1505 to Exert Its Immunomodulatory Activities in Local and Distal Mucosal Sites
por: Tomotsune, Kae, et al.
Publicado: (2022)

Oral Administration of Lacticaseibacillus rhamnosus CRL1505 Modulates Lung Innate Immune Response against Klebsiella pneumoniae ST25
por: Dentice Maidana, Stefania, et al.
Publicado: (2023)

1505. Predictive Value of Early Post-Transplant Bacteriuria on Rates of Recurrent Urinary Tract Infections in the First Year After Renal Transplantation
por: You, HoJoon, et al.
Publicado: (2018)

The Role of Alveolar Macrophages in the Improved Protection against Respiratory Syncytial Virus and Pneumococcal Superinfection Induced by the Peptidoglycan of Lactobacillus rhamnosus CRL1505
por: Clua, Patricia, et al.
Publicado: (2020)

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153
por: Waterhouse, David M., et al.
Publicado: (2020)

P1505: USING ARTIFICIAL INTELLIGENCE NEURAL NETWORKS TO OBTAIN AUTOMATED LIVER IRON CONCENTRATION MEASUREMENTS USING MAGNETIC RESONANCE IMAGING – A MULTI-SCANNER VALIDATION STUDY
por: St Pierre, T., et al.
Publicado: (2022)

The Ability of Postimmunobiotics from L. rhamnosus CRL1505 to Protect against Respiratory Syncytial Virus and Pneumococcal Super-Infection Is a Strain-Dependent Characteristic
por: Raya Tonetti, Fernanda, et al.
Publicado: (2022)

PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES
por: Olszewski, Adam, et al.
Publicado: (2023)

Correlation between nutrition, oral health, and different sarcopenia groups among elderly outpatients of community hospitals: a cross-sectional study of 1505 participants in China
por: Cao, Wenting, et al.
Publicado: (2022)

P1505: TOLERABILITY AND SAFETY OF INTRAVENOUS IMMUNOGLOBULINS (5% AND 10%) FOR THE TREATMENT OF PATIENTS WITH SECONDARY IMMUNODEFICIENCIES – FINAL SUBGROUP RESULTS OF A NON-INTERVENTIONAL SAFETY STUDY
por: Habier, Angela, et al.
Publicado: (2023)

BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol
por: Pasquier, David, et al.
Publicado: (2018)

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer
por: Chen, H, et al.
Publicado: (2014)

Gene methylation biomarkers in sputum as a classifier for lung cancer risk
por: Leng, Shuguang, et al.
Publicado: (2017)

Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study
por: Latorzeff, Igor, et al.
Publicado: (2021)

Comment on Yeste et al. Polyphenols and IUGR Pregnancies: Intrauterine Growth Restriction and Hydroxytyrosol Affect the Development and Neurotransmitter Profile of the Hippocampus in a Pig Model. Antioxidants 2021, 10, 1505
por: Garrabou, Glòria, et al.
Publicado: (2022)

Identification of a novel α(1→6) mannopyranosyltransferase MptB from Corynebacterium glutamicum by deletion of a conserved gene, NCgl1505, affords a lipomannan- and lipoarabinomannan-deficient mutant
por: Mishra, Arun K, et al.
Publicado: (2008)

Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial
por: Jia, Haiyan, et al.
Publicado: (2023)

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
por: Whisenant, Jennifer G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gniv24lkqoob7cbjtdnpu5c8ak